All lobbying filings

THE CONAFAY GROUP, LLC

THE CONAFAY GROUP, LLC filed a Q4 report for REVAGENIX, INC. on January 20, 2026, reporting $50,000 in lobbying income.

Lobbying for REVAGENIX, INC. · Biopharmaceutical company creating anti-infective medicines.

All filings by THE CONAFAY GROUP, LLC · Everything REVAGENIX, INC. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 3

BRYAN SHUY

Previously held: Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmte on Approps; Dep. Asst. Sec and Chief of Staff HHS/Asst.Secretary for Preparedness and Response (ASPR)
JOSH NARROW

Previously held: Intern to Senator Casey
DARIN L GARDNER

Previously held: Legislative Correspondent Senator Tim Hutchinson; Research Assistant Senate HELP Committee; Chief of Staff Congresswoman Kay Granger

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Opportunities to promote antimicrobial drug development.

Health Issues

Opportunities to promote antimicrobial drug development.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.